This panel featured Paul DellaNeve, Vice President, Moog Inc., Ulrich Nicolaus Kranz, Member of the Board and Chief Strategy Officer, Kiekert AG, Norman Rafael, Vice President, Corporate Development and Corporate Communications, Armacell International, S.A. Moderating the panel was McDermott Corporate Partner, Tom Conaghan, from the Firms Washington, DC office.

Drawing from the panellists different experience, the discussion focused on how each company approaches business development. Philosophies differed between the panellists. While some companies focus exclusively on their own portfolio and seek out acquisitions designed to grow the existing business platform, others admitted that some portion of their time and energy is devoted to discovering novel or unique businesses that may not fit squarely within a companys business lines. Strategic development officers must be open-minded and help their company see around cornersto help discover new and complementary products or business lines, not just acquire more market share in existing markets. Strategic development isnt only about growing immediate market share. It also involves understanding a companys critical supply chain and how the company makes the products it sells. Sometimes changes in the supply chain, notably regulatory changes, can force a companys hand and require strategic investments to help the company continue to make its products in a cost-effective way. In addition, strategic development officers need to understand how the market for its existing products may change and be prepared to help the company swiftly pivot into those markets to take advantage of new revenue opportunities.

Identifying the right target companies is also a complicated process, and each company tended to prioritize different things. Certainly, finding targets that contribute to top-line revenue growth is critical, but the panellist warned that cultural fit was just as important. 

Our panellists shared that they spent a lot of time with target management to confirm that the target shares the same philosophy and would fit into the companys culture. Valuation is also a key factor in identifying targets and completing deals. At this stage of their careers, our panellists had many interesting stories to share about the challenges involved in finding agreement with targets on appropriate value, and specifically how best to quantify the synergies that can be achieved in the business combination. Here is where legal advice can be most valuable, as the legal hurdles in integrating an acquired company, including from the point of view of human capital, commercial contractsand intellectual property, can translate into significant value gained (or lost) post-closing. Each of the panellists admitted that they have to start thinking about post-closing integration from the moment a target is identified.

Within their own organizations, it is important for strategy officers to deftly navigate the different internal constituencies within the company, from the businesses that are served to the other divisions, like the legal department, that help the strategy group execute on target acquisitions. Within companies with multiple business lines, not all of which may be in “growth” mode at the same time, it is important for chief strategy officers to deal with the politics.

The last portion of the panel was spent discussing the trendy topic of “disruptive technologies,” which can provide both opportunity and calamity for companies. Our panellists said that they are constantly looking at their space to try to make sure they avoid the negative impacts from the changing technology as well as find ways to capitalize on changing technology.

(Image 1/4)

Paul J. DellaNeve, Moog, Inc. (1/4); Ulrich-Nicolaus Kranz, Kiekert AG (2/4);
Norman R. Rafael, Armacell International S.A. (3/4); Tom P. Conaghan, McDermott Will & Emery (4/4)

Olivier Garnier, founder and managing partner of Bryan, Garnier & Co., and Khaled Bahi, Chief Financial Officer of Symetis, presented the acquisition of Symetis, the third largest player in the European market for transcatheter aortic valve implantation (TAVI), by Boston Scientific. Since its introduction in 2002 as a new ground-breaking procedure, TAVI has grown to become a $2.3 billion market with the expectation that it will increase to approximately $4 billion by 2020. Given the only alternative to treating Severe Aortic Stenosis (which affects 2 percent of the world population over the age of 65) is long and highly invasive open-heart surgery with general anaesthesia, it is not difficult to see why a procedure that requires only local anaesthesia and can be completed in 45 minutes...
1. The magic question: Is there an ideal investment funds structure for certain asset classes or investor types? With a view to market fund units to institutional investors, overseas funds usually have flexibility to adapt to individual investor requests, e.g., by setting up feeder fund structures. That flexibility allows tailoring to individual European fund investors requests. Further, overseas fund structures often do not have leverage restrictions and depositary bank requirements do not apply. As an important restriction, it is to be taken into account: Raising money in the EU is since 2013 a fully regulated activity subject to approval by the domestic investment fund supervisory authority. The resulting requirement is that raising money without having European AIFM-licence needs to be...

Olya Klüppel (Global Growth Capital), Jurij Puth (GSO), Jürgen Breuer (Pemperton Asset Management), Stuart Hewer (SEB), Dr Nicolaus Loos (IKB Deutsche Industriebank AG) and Didier Beltai-Menth (Bayerische Landesbank), discussed the current German debt finance environment and the competition between banks and (alternative investment/debt) funds as provider of financial accommodation. McDermott’s, Dr. Oliver K. Hahnelt moderated the panel discussion.

This panel featured the insights of Melville Mummert (Raymond James), Dr. Carsten Böhm (McDermott Will & Emery), Daniel Cole (Marlin Equity Partners Limited), Robert Goldstein (McDermott Will & Emery), Andreas Bösenberg (Sun European Partners) and Chris McIntire (KPM Analytics).The panel highlighted disruptive factors, such as the US administration, but ended with a fairly optimistic outlook for 2018....

Dr. Henrik Fastrich, Managing and Founding Partner of Orlando Management AG, Frank Gunther, Founder and Managing Director of One Square Advisors, Dr. Max Mayer-Eming, Managing Director of Macquarie Capital (Europe) Limited, and Martin Schwarzer, Partner and Co-head of the German Mergers & Acquisition group of PwC AG discussed the current restructuring and distressed M&A situation in the German market together with moderator Dr. Matthias Kampshoff of McDermott Will & Emery.

Dr. Christian Figge, Vice President, General Atlantic, Jennifer Kelly, Chief Executive Officer, Founder, Minxli, Dr. Sven Oleownik, Partner, Head of Germany, Gimv Germany, Christoph Weigler, General Manager Germany, Uber Germany and Dr. Thomas von Werner, Managing Director, EMH Partners, discussed the impact of digitalisation on the way they do business. Dr. Michael Cziesla, Partner Private Equity / M&A, McDermott Will & Emery, moderated the panel. The panel mainly covered the following three areas: How Big Data and Artificial Intelligence Changes the Way We Do Business Regulatory Challenges for Digital Platforms M&A in a Digital World – Threats and Opportunities The industry as a whole is changing massively as a result of digitalisation. The panel started by discussing the i...
Dr. Sven Oleownik, Partner and Head of Germany at Gimv Germany, discussed Gimv’s investment in Punch Powertrain, a Chinese-markets-oriented independent supplier of innovative, clean, powertrain technology. Dr. Oleownik showcased Gimv’s investment and exit process, as well as the strategic development all standing under the firm’s enquiry to get into the right market in China. Gimv, a European pioneer in Private Equity and Venture Capital, has a proven future-oriented strategy with a diversified portfolio of about 50 companies. Its key platforms of focus being smart industries, connected consumers, health care and sustainable cities. Building upon this strategy Gimv invested in the €35m EV (€15m equity and €20m debt) and negative E...
Dr. Florian von Alten, Managing Partner of Oaklins Germany, Dr. Michael Drill, CEO and Managing Director of Lincoln International AG, Carsten Hagenbucher, Managing Director for corporate investment in Europe of Investcorp, Philipp von Mitzlaff, Business Development Director of Paragon Partners GmbH and Brendan P. O’Connor, Assistant General Counsel for Mergers & Acquisitions and Assistant Secretary of Honeywell International Inc., together with panel head Dr. Nikolaus von Jacobs of McDermott Will & Emery discussed the M&A and Private Equity market in 2017. The panel dove into the current market, highlighting the positive atmosphere as an increasing number of investors chase the limited number of deals available. This competition among investors has continued to drive up prices,...
Dr. Stephan Rau and Kristian Werling, both from McDermott Will & Emery, moderated a thrilling panel on Health Care and Life Sciences M&A on both sides of the Atlantic. Hervé Ronin (Bryan Garnier & Co), Dr. Charles Niehaus (Alliance Medical), Benjamin Seifert (AUCTUS Capital Partners AG) and Dr. Oliver Schulte-Ladbeck (PwC) contemplated listing at the European state exchange, the competition of strategies and financials and the run for chief data officers (CDOs), chief marketing officers (CMOs) and other pharma services providers....
Olya Klüppel (ESO Capital Group), Mathias Wahrenberger (Burda Digital), Gunther Thies (STP Informationstechnol­ogie) and Christopher Brackmann (Bridgepoint), together with moderator David Evans (Alvarez & Marsal), discussed current trends affecting transactions in the technology, media and telecommunications (TMT) sector. The panel began with a discussion of the practical challenges and opportunities for software businesses moving from tradi­tional licence models to software as a service. The increased proportion of recurring revenues makes businesses that have successfully started this transition attractive to private equity investors and other finance providers, which in turn drives increasing valuation multiples in this space. The panellists agreed that a private equity investor cou...
The panel brought together representatives of family offices and family-backed investment vehicles from the United States and Europe; the discussion focused primarily on the challenges of cross-border direct investing. Each of the panellists noted the dramatic increase over the past few years of direct investing transactions, as well as the increased participation of family offices and family-backed investment vehicles in auctions and other competitive processes. The consensus was that this trend will continue and, in all likelihood, accelerate in the coming years. The panel was asked the following question: When you look at a cross-border investment opportunity, what strategies do you employ that might be different than in a domestic deal, for instance, around due diligence, local partner...
Ambassador Wolfgang Ischinger, chair of the Munich Security Conference, led the MuMAC audience through the recent changes that have shaken the international. Ambassador Ischinger believes that the current international climate is the most dangerous it has been since the end of the Cold War. Central to this change are the “Five Losses” to the international order: the losses of prediction, truth, Western self-confidence and trust in institutions, regional and global decision- making capability, and the state monopoly of power. From the complete surprise with which the international community was caught by events, such as the Crimean Crisis to the growing emergence of nationalistic tendencies around the world, and increasingly aggressive rogue states, Ambassador Ischinger highlighted how norm...